Skip to main content
Caplight Logo









Senté

Senté

Private
Carlsbad, CaliforniaHealthcare & Life Scienceshttps://sentelabs.com/

Last Round

Growth Equity

Apr 16, 2026

Total Funding Raised

$7.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Senté is a biotechnology-based skincare company that develops and markets medical-grade topical products featuring proprietary Heparan Sulfate Analog (HSA) technology for skin repair and anti-aging.

Sector

Healthcare & Life Sciences

Verticals

Fashion & Beauty, Biotechnology, D2C Brands, E-commerce

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical-grade skincarephysician-dispensed skincarecosmeceuticalsheparan sulfate analogHSAdermatologist recommendedskin barrier repairclinical skincaremedical aestheticsbiomimetic skincareprofessional skincareanti-aging treatmentsensitive skin careDTC skincaredoctor-brand

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Senté Comparables

Compare Senté with similar companies based on industry and business-model similarity.

Senté comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Episciences, Inc.
87%
Marini SkinSolutions
85%
Science of Skincare, LLC
84%

Senté Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityApr 16, 2026
VC RoundFeb 5, 2016
Series CJun 2, 2014
Series BMay 14, 2013

Key People

Founding team and executive leadership

Zubin Meshginpoosh

President & Chief Executive Officer

Executive Team

Senté Investors

Notable investors and investment history

Senté investors
InvestorRounds
ALMA Life SciencesGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 73% MoM.

  • Jul 26, 2026

    Monthly visitors increased 45% MoM.

Senté Filings

Explore SEC and related filing metadata, where available.

Senté filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Senté's valuation, stock price, and market status.

Is Senté a public or private company?

Senté is a private company.

What is the current stock price of Senté?

Senté is a private company with no public stock price. No recent secondary market data is available.

How much is Senté worth (valuation)?

Valuation information for Senté is not publicly available.

Can I buy Senté stock?

Senté shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Senté's last funding round?

Senté's most recent funding round was Growth Equity on April 16, 2026.

Who are the main investors in Senté?

Key investors in Senté include ALMA Life Sciences.

Will Senté IPO soon?

No public IPO plans have been announced for Senté.

How can I track Senté secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Senté's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCarlsbad, California
Employee Range30
Year Founded2007
Last FundingApr 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?